S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)2724-2726
Number of pages3
JournalEuropean heart journal
Volume40
Issue number32
DOIs
StatePublished - Aug 21 2019

Fingerprint

Myocardial Infarction
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{2008ab9724384b74a119203b4d658859,
title = "S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges",
author = "Frangogiannis, {Nikolaos G.}",
year = "2019",
month = "8",
day = "21",
doi = "10.1093/eurheartj/ehz524",
language = "English (US)",
volume = "40",
pages = "2724--2726",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "32",

}

TY - JOUR

T1 - S100A8/A9 as a therapeutic target in myocardial infarction

T2 - cellular mechanisms, molecular interactions, and translational challenges

AU - Frangogiannis, Nikolaos G.

PY - 2019/8/21

Y1 - 2019/8/21

UR - http://www.scopus.com/inward/record.url?scp=85071705822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071705822&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehz524

DO - 10.1093/eurheartj/ehz524

M3 - Article

C2 - 31334753

AN - SCOPUS:85071705822

VL - 40

SP - 2724

EP - 2726

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 32

ER -